Raltegravir-Based Regimens Are Effective in HIV-1 Group O-Infected Patients

被引:13
作者
Depatureaux, Agnes [1 ,2 ]
Leoz, Marie [1 ,2 ]
Le Moal, Gwenae [3 ]
Pathe, Jean-Paul [4 ]
Pavie, Juliette [5 ]
Batisse, Dominique [6 ]
Daneluzzi, Vincent [7 ]
Genet, Philippe [8 ]
Gerard, Laurence [5 ]
Lascaux-Cametz, Anne-Sophie [9 ]
Lambolez, Tessa [10 ]
Chennebault, Jean-Marie [11 ]
Plantier, Jean-Christophe [1 ,2 ]
机构
[1] CHU Charles Nicolle, Ctr Natl Reference 8, Rouen, France
[2] Univ Rouen, EA2656, GRAM, Rouen, France
[3] CHU La Miletrie, Serv Malad Infect, Poitiers, France
[4] CHI Eure Seine, Serv Med Interne, Evreux, France
[5] CHU St Louis, Serv Malad Infect, Paris, France
[6] Hop Europeen Georges Pompidou, Serv Immunol Clin, Paris, France
[7] CH Max Fourestier, Serv Malad Infect, Nanterre, France
[8] CH Victor Dupouy, Serv Hematol, Argenteuil, France
[9] CH Mondor, Serv Immunol Clin, Creteil, France
[10] CHG Longjumeau, Serv Med Interne & Infectiol, Longjumeau, France
[11] CHU Angers, Serv Malad Infect, Angers, France
关键词
TYPE-1 GROUP O; PHENOTYPIC SUSCEPTIBILITY; IN-VITRO; INTEGRASE VARIABILITY; EXPERIENCED PATIENTS; GENETIC BARRIER; INHIBITORS; DIAGNOSIS; SUBTYPES; POLYMORPHISM;
D O I
10.1097/QAI.0b013e31826327c4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:E1 / E3
页数:3
相关论文
共 25 条
[1]  
[Anonymous], 2009, AIDS ALERT, V24, P93
[2]   Subtype Diversity Associated with the Development of HIV-1 Resistance to Integrase Inhibitors [J].
Brenner, Bluma G. ;
Lowe, Matthew ;
Moisi, Daniela ;
Hardy, Isabelle ;
Gagnon, Simon ;
Charest, Hugues ;
Baril, Jean Guy ;
Wainberg, Mark A. ;
Roger, Michel .
JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (05) :751-759
[3]   Raltegravir and Etravirine Are Active against HIV Type 1 Group O [J].
Briz, Veronica ;
Garrido, Carolina ;
Poveda, Eva ;
Morello, Judit ;
Barreiro, Pablo ;
de Mendoza, Carmen ;
Soriano, Vincent .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) :225-227
[4]   In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572 [J].
Charpentier, Charlotte ;
Larrouy, Lucile ;
Collin, Gilles ;
Damond, Florence ;
Matheron, Sophie ;
Chene, Genevieve ;
Nie, Ting ;
Schinazi, Raymond ;
Brun-Vezinet, Francoise ;
Descamps, Diane .
AIDS, 2010, 24 (17) :2753-2755
[5]   Specific diagnosis and follow-up of HIV-1 group O infection RES-O data [J].
Depatureaux, A. ;
Leoz, M. ;
De Oliveira, F. ;
Gueudin, M. ;
Damond, F. ;
Descamps, D. ;
Brun-Vezinet, F. ;
Lemee, V. ;
Simon, F. ;
Barin, F. ;
Plantier, J-C .
MEDECINE ET MALADIES INFECTIEUSES, 2010, 40 (12) :669-676
[6]  
Depatureaux Agnes, 2011, J Acquir Immune Defic Syndr, V56, P139, DOI 10.1097/QAI.0b013e318201a904
[7]   Baseline Genotypic and Phenotypic Susceptibilities of HIV-1 Group O to Enfuvirtide [J].
Depatureaux, Agnes ;
Charpentier, Charlotte ;
Collin, Gilles ;
Leoz, Marie ;
Descamps, Diane ;
Vessiere, Aurelia ;
Damond, Florence ;
Rousset, Dominique ;
Brun-Vezinet, Francoise ;
Plantier, Jean-Christophe .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) :4016-4019
[8]   Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses [J].
Descamps, D ;
Collin, G ;
Letourneur, F ;
Apetrei, C ;
Damond, F ;
LoussertAjaka, I ;
Simon, F ;
Saragosti, S ;
BrunVezinet, F .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8893-8898
[9]   Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection [J].
Garrido, Carolina ;
Geretti, Anna Maria ;
Zahonero, Natalia ;
Booth, Clare ;
Strang, Angela ;
Soriano, Vincent ;
De Mendoza, Carmen .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) :320-326
[10]   Virologic diagnosis and follow-up of children born to mothers infected by HIV-1 Group O [J].
Gueudin, M ;
Lemée, V ;
Ferre, V ;
Beby-Defaux, A ;
Pathé, JP ;
Guist'hau, O ;
Braun, J ;
Simon, F ;
Plantier, JC .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) :639-641